Imaging quantification of chemotherapy and endocrine therapy induced fatty liver in breast cancer
RONG Dailin
YANG Qiuxia
XU Shuhang
ZHAO Qianqian
ZHANG Rong
Abstract：Fatty liver is the most common complication in liver during the chemotherapy and endocrine therapy in breast cancer, usually in a level of mild-to moderate. However some severe complications may occur, such as fibrosis, cirrhosis, liver cancer, and liver failure. Since hepatic steatosis is reversible, a dynamically quantitative assessment of hepatic steatosis can contribute to a early diagnosis and intervention, which may provide references for the clinical evaluation and treatment. So far, a variety of noninvasive imaging methods is proposed to identify and assess hepatic steatosis quantitatively, but their sensitivity varies. In this review, we focused on the application of imaging methods in the early diagnosis and quantification of chemotherapy and endocrine therapy induced fatty liver.
Keywords：Fatty liverBreast cancerChemotherapyEndocrinotherapyUltrasoundTomographyX-ray computedMagnetic resonance imagingMagnetic resonance spectroscopy
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 51-55 )